JOSEPH KHOURY to DNA-Binding Proteins
This is a "connection" page, showing publications JOSEPH KHOURY has written about DNA-Binding Proteins.
Connection Strength
0.455
-
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow. Am J Hematol. 2013 Dec; 88(12):1055-61.
Score: 0.178
-
Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3692-9.
Score: 0.089
-
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells. Blood Cancer J. 2021 05 20; 11(5):98.
Score: 0.076
-
Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations. Br J Haematol. 2018 05; 181(3):305.
Score: 0.060
-
Activation status of the JAK/STAT3 pathway in mantle cell lymphoma. Arch Pathol Lab Med. 2005 Aug; 129(8):990-6.
Score: 0.025
-
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm. Blood Adv. 2023 05 23; 7(10):2000-2003.
Score: 0.022
-
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004 Jul 15; 104(2):328-35.
Score: 0.006